drugset

drugset / Trial / NCT00524836

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

NCT00524836 ↗

Phase 3 Completed 71 enrolled UCB Pharma

RandomizedParallel-groupSingle-blindTreatment

Summary

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis.

Timeline

Start: 2003-09
Primary completion: 2004-02
Completion: 2004-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levocetirizine	Unknown	5 mg	Oral

Indications